100.87 0.00 (0.00%)
After hours: 5:08PM EDT
|Bid||100.74 x 800|
|Ask||100.76 x 1000|
|Day's Range||99.66 - 100.98|
|52 Week Range||78.95 - 115.64|
|Beta (3Y Monthly)||0.89|
|PE Ratio (TTM)||19.32|
|Forward Dividend & Yield||2.12 (2.12%)|
|1y Target Est||N/A|
Quest Diagnostics' (DGX) frequent partnership wins with health care leaders and sensible buyouts are creating bountiful opportunities for the top and the bottom line.
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quest Diagnostics Inc NYSE:DGXView full report here! Summary * Perception of the company's creditworthiness is positive * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for DGX with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $3.37 billion over the last one-month into ETFs that hold DGX are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | PositiveThe current level displays a positive indicator. DGX credit default swap spreads are within the middle of their range for the last three years.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Today we'll take a closer look at Quest Diagnostics Incorporated (NYSE:DGX) from a dividend investor's perspective...
Chairman, President and CEO of Quest Diagnostics Inc (NYSE:DGX) Stephen H Rusckowski sold 244,565 shares of DGX on 06/13/2019 at an average price of $100 a share.
Opko Health Inc said on Thursday it was notified by its former billing collections vendor about unauthorized access to information on about 422,600 customers, making it the third healthcare company to be affected by the incident. American Medical Collection Agency (AMCA) informed Opko Health that the compromised data may include credit card and bank account information, email addresses and other data such as address, phone number and balance information. Earlier this week, rivals Quest Diagnostics Inc and Laboratory Corporation of America Holdings also announced that they were apprised of unauthorized access to their customer data stored on AMCA system.
Senators demand answers from Quest Diagnostics and LabCorp after a data breach may have put millions of consumers' information at risk.
The conclusion of LabCorp's (LH) swap transaction will help enhance the company's Covance global nonclinical drug development capabilities with additional sites and resources.
Quest Diagnostics Inc., one of the biggest blood testing providers in the country, has suffered a massive hack possibly affecting millions of its customers. The company confirmed Monday that nearly 12 million people may have had personal, financial and medical information breached due to an issue with one of its vendors. In a filing with the U.S. Securities and Exchange Commission, Quest explained that someone had unauthorized access to the systems of American Medical Collections Agency (AMCA), a billing services vendor.
The company has not received all the information about the incident from American Medical Collection Agency (AMCA) and has not been able to verify the accuracy of the information received from AMCA, the diagnostic information services provider said https://www.sec.gov/Archives/edgar/data/1022079/000094787119000415/ss138857_8k.htm. Optum360 LLC, a unit of UnitedHealth Group Inc, was also notified of the breach, according to Quest's regulatory filing. Optum360 provides customer billing services to Quest Diagnostics.
Medical testing giant Quest Diagnostics has confirmed a third-party billingcompany has been hit by a data breach affecting 11
In 1970 Steve Rusckowski was appointed CEO of Quest Diagnostics Incorporated (NYSE:DGX). This analysis aims first to...